Award details

Transition state analysis to guide drug discovery.

Reference	BB/T004088/1
Principal Investigator / Supervisor	Professor Mark Wheatley
Co-Investigators / Co-Supervisors	Dr David Poyner, Dr John Simms
Institution	Coventry University
Department	Ctr for Sport, Exercise and Life Science
Funding type	Research
Value (£)	177,497
Status	Completed
Type	Research Grant
Start date	01/04/2020
End date	30/06/2022
Duration	27 months

Abstract

unavailable

Summary

There is an urgent need to find better methods to discover drugs. A third of clinical drugs target G-protein-coupled receptors (GPCRs). When a GPCR is activated by a drug, it changes its structural shape (conformation). Activation proceeds via a series of structural intermediates. The pathway of intermediate conformations dictates the intracellular signalling pathway activated by the drug:receptor complex. Currently it is not possible to predict if a drug will signal (efficacy) and by which pathway (signalling bias). We have developed a computational approach (Transistion State Analysis) that models intermediate conformational states as receptors are activated. Our method accurately predicted efficacy and bias of drugs at two GPCRs. Prior to commercialisation, we need to validate our methods using a wider range of therapeutic targets and drugs. This technology will accelerate drug discovery, saving time and money, and have significant end-user impact.

Committee	Not funded via Committee
Research Topics	Structural Biology
Research Priority	X – Research Priority information not available
Research Initiative	Follow-On Fund (FOF) [2004-2015]
Funding Scheme	X – not Funded via a specific Funding Scheme

I accept the terms and conditions of use (opens in new window)

export PDF file

back to list new search